Irish-led firm expects sale of stake in Swedish rare minerals project in ‘near future’
Cathal Friel’s European Green Transition hopes sale will allow it focus on revenue generating opportunities in the green energy transition
Cathal Friel
European Green Transition begins drilling at rare earth element project in Sweden
Company says results may help it attract a partner for the project
Clinical trials group Hvivo announces departure from Irish stock market
Company says its primary operations, along with the majority of its employees and investor base, are based in the UK
Irish Life has paid €1.73bn in dividends to overseas parent since it was bought from the State a decade ago
The best news, analysis and comment from The Irish Times business desk
Ireland’s Mr IPO and his plans to make more companies public
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Hvivo chairman Cathal Friel sells remaining shares for €7.3m
Businessman oversaw the initial flotation in 2019 of clinical trials group that became Hvivo
Glandore’s Michael Kelly increases his stake in Poolbeg Pharma
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
European Green Transition takes option on copper remnants from Cypriot mine
Irish entrepreneur Cathal Friel orchestrated the flotation of company earlier this month
Cathal Friel’s green transition firm shares rise in London debut
IPO is fifth put together by Irish serial entrepreneur Cathal Friel in past dozen years
Irish-led green transition firm raises initial €7.6m in London IPO
Funding garnered from institutional investors and family offices
Cathal Friel-chaired green transition firm announces London IPO plan
Friel orchestrated the IPO of Open Orphan in 2019 through the reverse takeover of Dublin-listed Venn Life Sciences
Pharmaceutical services company Hvivo sells almost 30m placing shares
New and existing institutional investors indicated demand for shares was in excess of those available
Open Orphan subsidiary signs deal with global pharma company
Deal will see hVivo manufacture virus for use in human challenge studies
Investors to buy €1.9m shares in Poolbeg Pharma
Largest individual investor understood to be an experienced life science investor
Open Orphan says Covid infection study may accelerate new vaccines
Shares in Open Orphan were up almost 5% in late morning trading in London
Open Orphan subsidiary signs €6m contract for respiratory study
Company expects revenues from the contract to be recognised across 2022 and 2023
Open Orphan appoints Yamin Khan as new chief executive
Cathal Friel to continue in executive chairman role under new management structure
Potential RSV vaccine achieves regulatory step in US
Bavarian Nordic vaccine candidate used hVivo challenge trial to gather data
‘Human challenge’ Covid trial gives new insight into virus
Open Orphan test shows shorter incubation period, effectiveness of lateral flow tests
Open Orphan subsidiary signs £1.5m contract renewal
Contract to study absorption, distribution, metabolism and excretion of drugs in body
Open Orphan subsidiary signs €6.7m contract for flu study
Influenza could be a major global issue due to low immunity caused by reduced infection
Open Orphan wins €9.5m asthma contract with major pharma company
Study is being carried out under asthma human challenge study model
Open Orphan subsidiary develops human study for malaria
Healthy volunteers are administered a pathogenic or virulent strain of virus
NatWest to take Permanent TSB stake in Ulster Bank loans transfer
Seen & heard: global tax rate above 15%; phasing out leasing of social housing; Poolbeg to seek Nasdaq listing
Open Orphan pharmaceutical company expands Covid-19 trial
Challenge study is providing valuable insight into biology of the virus, firm says
Open Orphan spin-out Poolbeg Pharma to list on London market
Company will use money from listing to meet costs for flu drug trials, develop assets
Open Orphan gets approval to reduce capital ahead of spin-out
Company says reduction of capital will allow it to return value to its shareholders
Open Orphan plans for possible spin-out of non-core assets
Company says HVO-001 could be included as part of potential demerger
Failure to reform State pension age could cost up to €50bn
Seen and Heard: Quinlan bankruptcy case set for June; Hammerson stuck for Ilac tenants
Open Orphan subsidiary wins €7.5m contract to run study
Contract with US biotechnology company concerns a respiratory syncytial virus
Open Orphan company successfully completes nasal spray study
Prophylactic spray could be used against Covid-19
Open Orphan renews contract with major pharma company
Dublin-listed pharmaceutical services company says new deal will run for another year
Open Orphan gets green light for Covid-19 nasal vaccine trial
Vaccine could be one of the first to provide long-term immunity from Covid-19
Venn Life Sciences wins another Covid-19 drug study
Open Orphan subsidiary to manage Phase 2 clinical trial for European pharma company
Open Orphan subsidiary takes lead role on guidelines for human challenge agents
Guidelines will cover manufacture of agents for use in controlled infection studies
Open Orphan signs two year contract with German pharma company
Contract guarantees annual revenue for Dublin listed company
Open Orphan subsidiary hVivo signs deal for Covid-19 challenge study
Contract with UK government could be worth up to £10m
Open Orphan eyes profitability as it reports £4.1m ebitda loss
Company led by Cathal Friel recorded revenues of £7.1m for its first half
Open Orphan wins contract to support European pharma giant
Paris subsidiary Venn Life Sciences to work with oncology study enrolling 750 subjects
EY Entrepreneur of the Year international finalists focusing on growth
Sectors include health and safety, pharma, crop protection and refrigeration
Open Orphan wins €4m contract to conduct trial for new RSV treatment
Dublin-listed pharmaceutical services company says contract is with top three pharma group
Open Orphan deal to generate ‘significant revenue’ for Venn Life Sciences
New contract with Japanese company Carna Bioscience follows close collaboration on drug development planning and pre-clinical activities
Open Orphan signs deal to carry out Covid-19 vaccine trial
Dublin listed company will carry out phase one trial at Hvivo facility
Open Orphan signs option to acquire company for ‘nominal sum’
The pharmaceutical company has three months to acquire CHIMagents
Open Orphan develops first challenge study model to test Covid-19 vaccines
Dublin-listed pharmaceutical services company publishes annual results for 2019
Open Orphan sees positive trial on mosquito-borne disesases
Company is developing a vaccine to guard against diseases such as malaria and zika
EY selects 24 finalists to battle for Entrepreneur of the Year award
Tech and life sciences businesses well represented in addition to traditional players
Open Orphan signs big deal with vaccine manufacturer
Agreement covers market access of newly developed medicine into EU and US markets
Open Orphan launches Covid-19 antibody testing service
London subsidiary Hvivo will carry out testing at its lab with 48-hour turnaround
Open Orphan raises €13.4m to ramp up Covid-19 study
Challenge study models could speed up the development of a vaccine by up to three years
Covid-19: Open Orphan to carry out 3,000 antibody tests per day
Antibody tests can detect if a person has had coronavirus before and has since recovered
Irish companies come out in force to help during Covid-19 pandemic
Issues with everything from drug trials to tech solutions, patient care are being tackled
Dublin-listed Open Orphan to test Covid-19 drug through London subsidiary
As many as 100 potential Covid-19 candidate vaccines are now under development by biotech and research teams around the world
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices